Clinical Trial Update: Isentress Re-examination Study (MK-0518-115)

View source ↗

Summary

Clinical trial update noting that the Isentress re-examination study MK-0518-115 has completed. The study concerns HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Isentress (Raltegravir)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: HIV Infection, HIV Infections | Status: COMPLETED